ALT5 Sigma Corporation

ALT5 Sigma Corporation (formerly JanOne Inc.) operates a biotechnology segment, now known as its subsidiary “Alyea Therapeutics.” The company explicitly admits to conducting animal studies to test the efficacy and safety of these drugs.

Supporting Evidence:

The company confirms in corporate disclosures that it utilizes animal subjects for product testing.

“Studies were performed to determine whether nitrite mediated therapy would be effective in tissue that had been left ischemic for 5 days after femoral artery ligation. Femoral artery ligation was performed in C57BL/6J mice and the animals randomized to either PBS or sodium nitrite therapy 5 days after artery ligation.” (Page 23) Read the full document